| Name | Title | Contact Details |
|---|
Nautilus, Inc. is an iconic industry leader with a rich history and reputation as an innovative company building the best cardio and strength equipment for home use. Known for its family of brands that includes Bowflex®, Nautilus®, and Schwinn® Fitness, Nautilus, Inc. develops, manufacturers and markets branded products that include strength, cardio and fitness accessories through direct and retail channels. With its headquarters and innovation center located in Vancouver, Washington, Nautilus, Inc. employs nearly 500 employees and has offices in Brooklyn Park, Minnesota and Shanghai, China, as well as distribution centers in Portland, Oregon, Columbus, Ohio, and Rotterdam, The Netherlands.
TAKE is an industry leader in providing the following services to Pharmaceutical companies such as: CDISC Services, where we offer the most effective data standardization solutions and consulting services. The OneClinical team under the leadership of a
Midwestern Connecticut Council on Alcoholism (MCCA) is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Midwestern Connecticut Council on Alcoholism (MCCA) is based in Danbury, CT. You can find more information on Midwestern Connecticut Council on Alcoholism (MCCA) at www.mccaonline.com
Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.